Pharmafile Logo

Lucid tackles Tough Mudder 2017

- PMLiVELast Saturday, twenty enthusiastic Lucidians took on the 2017 London South Tough Mudder Half challenge at the Holmbrush Estate in Surrey. Covering 5 miles and 13 imposing obstacles, the team tested their strength, endurance and teamwork – for charity. Prior to the event, they raised over £1800 for the charities Genetic Alliance UK and Bloodwise, in addition to supporting Tough Mudder’s official charity partner, Help for Heroes.

Lucid’s charity fundraising efforts were initiated by Team Marvel, who were soon joined in their mission by colleagues from across the Lucid Group. The brave participants assembled on the chilly Saturday morning, cheered on by their supporters in the crowd. “Faced with exorbitant enthusiasm by some and a little trepidation by others, we all supported each other through the race, and had a great time while we did,” said Ayala Donegan, Customer Experience Manager at Lucid.

Andrew Owen, Divisional Director and Lucid Charity Working Group leader, commented: “Collaboration to advance outcomes is at the heart of everything we do at Lucid, and our approach to charity is no different. Many people at Lucid have collectively chosen to participate in Tough Mudder because it’s a great way to support charities that share our vision, and is also an activity that’ll bring us together as a team, overcoming the pretty terrifying-looking obstacles and hopefully having fun on the way! I’m so proud that so many of us are taking part, that the entire company is supporting us, and that we can do something as a company collectively to support such worthwhile causes.”- PMLiVE

- PMLiVE

- PMLiVE

- PMLiVE

- PMLiVE

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid celebrate big wins at PMEA 2015

Success for Lucid at PMEA 2015

Lucid invests in their Futures programme with a new hire

Lucid Group continues their expansion

Janus kinase inhibitors are amongst the most read abstracts at the American College of Rheumatology 2015

Rheumatologists eagerly await trial data for Janus kinase inhibitors

Making a difference to patients with IBD

Changing lives with medical education

Lucid Group showcases new KOL identification and mapping tool

Advancing Expert identification with digital new tool from Lucid Group

Lucid CEO discusses his inspiration and passion for changing patients’ lives

Changing patients' lives with innovative methodologies in medical education

Lucid Group starts new trend for CME in IBD education

A tailored educational event in IBD